{
    "organizations": [],
    "uuid": "708de0edb26e7030aeaa7dc92695923838c69441",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ferring-says-specific-financial-de/brief-ferring-says-specific-financial-details-of-transaction-with-ligand-pharma-are-not-disclosed-idUSASM000ICR",
    "ord_in_thread": 0,
    "title": "BRIEF-Ferring Says Specific Financial Details Of Transaction With Ligand Pharma Are Not Disclosed​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 22, 2018 / 2:56 PM / Updated 12 minutes ago BRIEF-Ferring Says Specific Financial Details Of Transaction With Ligand Pharma Are Not Disclosed​ Reuters Staff \nJan 22 (Reuters) - ‍Ferring Pharmaceuticals: \n* FERRING ENTERS INTO WORLDWIDE OMNIAB® PLATFORM LICENSE AGREEMENT WITH LIGAND \n* ‍FERRING PHARMACEUTICALS SAYS SPECIFIC FINANCIAL DETAILS OF TRANSACTION WITH LIGAND PHARMA ARE NOT DISCLOSED​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-22T16:55:00.000+02:00",
    "crawled": "2018-01-22T17:14:52.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "specific",
        "financial",
        "detail",
        "transaction",
        "ligand",
        "pharma",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "pharmaceutical",
        "ferring",
        "enters",
        "worldwide",
        "platform",
        "license",
        "agreement",
        "ligand",
        "pharmaceutical",
        "say",
        "specific",
        "financial",
        "detail",
        "transaction",
        "ligand",
        "pharma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}